At SIRO, our goal is clear: to play a pivotal role in drug development and help lifesavers save lives. Our clinical operations team brings over two decades of experience across all phases of clinical studies, coupled with expertise in niche therapeutic areas. We partner strategically with our clients, optimizing trial design and navigating regulatory pathways with innovative approaches. Our integrated 'One Data One Team' approach ensures strong subject recruitment and retention, faster start-up timelines, and efficient project management for increased site productivity and data quality. Strong governance ensures a smooth study experience and provides solutions to our clients' therapeutic, regulatory, and operational challenges.
Our Legacy of Excellence
28+
100+
300+
10K+
Our Journey of
Innovation and Excellence
1996
Embarked on our journey as SIRO in Mumbai, India.
2001
Pioneered services in biostatistics, data management, and medical writing.
2007
Achieved recognition with the Frost & Sullivan 'Partner of Choice' award for clinical trials in India.
2011
Honoured with the Frost and Sullivan 'Clinical Research Organization of the year' India Healthcare award.
2012
Earned consecutive Frost and Sullivan 'Clinical Research Organization of the year' India Healthcare awards.
2013
Emerged as the largest contract medical writing agency in Asia.
2015
Diversified into new business verticals including medical communications and data analysis.
2016
Recognized as the 'Best clinical research company' at the Healthcare and Fitness Leadership Awards 2016.
2019
Acknowledged as the Best SME in 'Education and Health Services' at the Dun and Bradstreet SME Business Excellence Awards 2019.
2022 & 2023
Expanded our global presence with operations in the UK and Singapore. Awarded Silver medal for EcoVadis Rating. Honoured with the 'Frost and Sullivan' Customer Value Leadership Award's, affirming our excellence in the Indian Contract Research Organization Industry.
2024
SIRO earns Frost & Sullivan's 2024 Global Customer Value Leadership.